Rapport Therapeutics Inc

RAPPNASDAQ · US

Holders

REDUCEDT+7
Ceesay Abraham
Rapport Therapeutics Inc · NASDAQ
−1,147 sh · $35.2K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Ceesay Abraham
Rapport Therapeutics Inc · NASDAQ
−3,375 sh · $108.1K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+30
Gault Cheryl
Rapport Therapeutics Inc · NASDAQ
−2,075 sh · $70.0K
Filed 1 Oct 2026SEC Form 4view source
REDUCEDT+30
Gault Cheryl
Rapport Therapeutics Inc · NASDAQ
−7,925 sh · $261.8K
Filed 1 Oct 2026SEC Form 4view source
REDUCEDT+30
Ceesay Abraham
Rapport Therapeutics Inc · NASDAQ
−1,952 sh · $76.2K
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Ceesay Abraham
Rapport Therapeutics Inc · NASDAQ
−43 sh · $1.8K
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Ceesay Abraham
Rapport Therapeutics Inc · NASDAQ
−215 sh · $8.6K
Filed 24 Sept 2026SEC Form 4view source
REDUCEDStale
Ceesay Abraham
Rapport Therapeutics Inc · NASDAQ
−7,141 sh · $325.3K
Filed 9 Sept 2026SEC Form 4view source
REDUCEDStale
Ceesay Abraham
Rapport Therapeutics Inc · NASDAQ
−1,069 sh · $49.2K
Filed 9 Sept 2026SEC Form 4view source
REDUCEDStale
Yeleswaram Krishnaswamy
Rapport Therapeutics Inc · NASDAQ
−13,160 sh · $658.0K
Filed 26 Aug 2026SEC Form 4view source